Central nervous system infections in individuals with HIV-1 infection

References

• Albrecht H, Hoffmann C, Degen O, Stoehr A, Plettenberg A, Mertenskotter T, Eggers C, Stellbrink HJ (1998). HAART significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoen-cephalopathy. AIDS 12: 1149–1154.
   PubMed Web of Science ®Google Scholar
• Antinori A, Cingolani A, De Luca A, Gaidano G, Ammassari A, Larocca L, Ortona L (1999). Epstein-Barr virus in monitoring the response to therapy of acquired immun-odeficiency syndrome-related primary central nervous system lymphoma. Ann Neurol 5: 259–261.
   Google Scholar
• Arribas JR, Clifford DB, Fichtenbaum CJ, Roberts RL, Powderly WG, Storch GA (1995a). Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma. J Clin Micro 33: 1580–1583.
   PubMed Web of Science ®Google Scholar
• Arribas JR, Clifford DB, Fichtenbaum CJ, Commins DL, Powderly WG, Storch GA (1995b). Level of CMV DNA in cerebrospinal fluid of subjects with AIDS and CMV infection in the central nervous system. I Infect Dis 172: 527–531.
   PubMed Web of Science ®Google Scholar
• Astrom KE, Mancall EL, Richardson EP (1958). Progressive multifocal leukoencephalopath y. Brain 81: 92–111.
   Google Scholar
• Berger JR, Kaszovitz B, Post J, Dickinson G (1987). Progres-sive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. Ann Intern Med 107: 78–87.
   PubMed Web of Science ®Google Scholar
• Berger JR, Mucke L (1988). Prolonged survival and par-tial recovery in AIDS-associated progressive multifocal leukoencephalopath y. Neurol 38: 1060–1065.
   PubMed Web of Science ®Google Scholar
• Berger JR, Pall L, Lanska D, Whiteman M (1998). Progres-sive multifocal leukoencephalopathy in patients with HIV infection. J NeuroVirol 4: 59–68.
   Google Scholar
• Berman SM, Kim RC (1994). The development of cy-tomegalovirus encephalitis in AIDS patients receiving ganciclovir. Am J Med 96: 415–419.
   PubMedGoogle Scholar
• Brambilla AM, Castagna A, Novati R, Cinque P, Terreni MR, Moioli MC, Lazzarin A (1999). Remission of AIDS-associated progressive multifocal leukoencepha - lopathy after cidofovir therapy. I Neurology 246: 723–725.
   Google Scholar
• Chamberlain M, Kormanik P (1999). AIDS-related cen-tral nervous system lymphomas. I NeuroOncol 43: 269–276.
   PubMed Web of Science ®Google Scholar
• Chang L, Miller B, McBride D, Cornford M, Oropilla G, Buchtal S, Chiang F, Aronow H, Beck CK, Ernst T (1995). Brain lesions in patients with AIDS: H-1 MR spec-troscopy. Radiology 197: 525–531.
   Google Scholar
• Chowdhury M, Kundu M, Khalili K (1993). GA/GC-rich sequence confers Tat responsiveness to human neu-rotropic virus promoter, JCV, in cells derived from cen-tral nervous system. Oncogene 8: 887–892.
   PubMed Web of Science ®Google Scholar
• Cingolani A, De Luca A, Ammassari A, Murri R, Linzalone A, Grillo R, Antinori A (1996). PCR detection of Toxo-plasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions. I Med Microbiol 45: 472–476.
   PubMed Web of Science ®Google Scholar
• Cingolani A, De Luca A, Larocca L, Ammassari A, Scer-rati M, Antinori A, Ortona L (1998). Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. I Nat] Cancer Inst 90: 364–369.
   Google Scholar
• Cinque P, Baldanti F, Vago L, Terreni M, Lillo F, Furione M, Castagna A, Monforte A, Lazzarin A, Linde A (1995). Ganciclovir therapy for cytomegalovirus infection of the central nervous system in AIDS patients: monitoring by CMV DNA detection in cerebrospinal fluid. I Infect Dis 171: 1603–1606.
   Google Scholar
• Cinque P, Vago L, Dahl H, Brytting M, Terreni M, Fornara C, Racc a S, Castagna A, Monforte A, Wa hren B, Lazzarin A, Linde A (1996). Polymerase chain reaction on cere-brospinal fluid for diagnosis of virus-associated oppor-tunistic diseases of the central nervous system in HIV-infected patients. AIDS 10: 951–958.
   PubMed Web of Science ®Google Scholar
• Cinque P, Cleator GM, Weber T, Monteyne P, Sindic C, Gerna G, van Loon A, Klapper P (1998). Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. I NeuroVirol 4: 120–132.
   Web of Science ®Google Scholar
• Clifford DB, Arribas JR, Storch GA, Tourtellote W, Wippold FJ (1996). Magnetic resonance brain imaging lacks sensi-tivity for AIDS associated cytomegalovirus encephalitis. J NeuroVirol 2: 397–403.
   PubMed Web of Science ®Google Scholar
• Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE (1999). HAART improves prognosis in HIV-associated progressive mul-tifocal leukoencephalopathy. Neurology 52: 623–625.
   PubMed Web of Science ®Google Scholar
• Cohen B (1999). Neurologic manifestations of toxoplasmo-sis in AIDS. Semin Neurol 19: 201–.
   Web of Science ®Google Scholar
• Corn B, Donhaue B, Rosenstock J, Hyslop T, Brandon A, Hegde H, Cooper J, Sherr D, Fisher S, Berson A, Han H, Abdel-Wahab M, Koprowski C, Ruffer J, Curran W (1997). Performance status and age as independent pre-dictors of survival among AIDS patients with primary CNS lymphoma: a multivariate analysis of a multi-institutional experience. Cancer J Sci Am 3: 52–56.
   Google Scholar
• Dannemann B, McCutchan A, Israelski D, Antoniskis D, Leport C, Luft B, Nussbaum J, Clumeck N, Morlat P, Chiu J, Vilde J, Orellana M, Feigal D, Bartok A, Heseltine P, Leedom J, Remington J (1992). Treatment of toxoplasmic encephalitis in patients with AIDS. Ann of Intern Med 116: 33–43.
   PubMed Web of Science ®Google Scholar
• DeLuca A, Cingolani A, Linzalone A, Ammassari A, Murri R, Giancola M, Maiuro G, Antinori A (1996). Improved detection of JC virus DNA in cerebrospinal fluid for diagnosis of AIDS-related progressive multifocal leukoen-cephalopathy. I Clin Micro 34: 1343–1346.
   Google Scholar
• DeLuca A, Giancol a ML, Cingolani A, Ammassari A, Gillini L, Murri R, Antinori A (1999). Clinical and virolgical monitoring during treatment with intathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 28: 624–628.
   Google Scholar
• DeLuca A, Giancol a ML, Ammassari A, Grisetti S, Cingolani A, Paglia M, Govoni A, Murri R, Testa L, Monforte A, Antinori A (2000). Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopath y. AIDS 14: 117–121.
   Google Scholar
• Dworkin MS, Wan PC, Hanson DL, Jones JL, Adult and Adolescent Spectrum of HIV Disease Project (1999). Progressive multifocal leukoencephalopathy: improved survival of HIV-infected patients in the protease in-hibitor era. I Infect Dis 180: 621–625.
   PubMed Web of Science ®Google Scholar
• Ferrante P, Calderelli-Stefano R, Omodeo-Zorini E, Vago L, Boldorini R, Costanzi G (1995). PCR detection of JC virus DNA in brain tissue from patients with and with-out progressive multifocal leukoencephalopath y. I Med Virol 47: 219–.
   PubMed Web of Science ®Google Scholar
• Fessler RD, Sobel J, Guyot L, Crane L, Vazguez J, Szub a M, Diaz F (1998). Management of elevated intracranial pres-sure in patients with cryptococcal meningitis. I AIDS Human Retrovirol 17: 137–142.
   PubMedGoogle Scholar
• Fine H, Mayer R (1993). Primary central nervous system lymphoma. Ann Intern Med 119: 1093–1104.
   PubMed Web of Science ®Google Scholar
• Flinn I, Ambinder R (1996). AIDS primary central nervous system lymphoma. Curr Opin Oncol 8: 373–376.
   Google Scholar
• Fong IW, Toma E, Canadian PML Study Group (1995). The natural history of progressive multifocal leukoen-cephalopathy in patients with AIDS. Clin Infect Dis 20: 1305–1310.
   PubMed Web of Science ®Google Scholar
• Friedman PD, Samore MH, Kraemer KL, Calkins DR (1995). Clinical correlates of secondary meningitis in HIV-infected adults. Arch Intern Med 155: 2231–2237.
   Google Scholar
• Furrer H, Opravil M, Bernasconi E, Telenti A, Egger M (2000). Stopping primary prophylaxis in HIV-1-infected patients at high risk of toxoplasma encephalitis. Lancet 355: 2217–2218.
   Google Scholar
• Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE, zidovudine epidemiology group (1992). Incidence and natural history of cytomegalovirus disease in pa-tients with advanced human immunodeficiency virus disease treated with zidovudine. I Infect Dis 166: 1223–1227.
   PubMed Web of Science ®Google Scholar
• Hall CD, Dafni U, Simpson D, Clifford D, Wetherill P, Cohen B, McArthur J, Hollander H, Yiannoutsos C, Major E, Millar L, Timpone J (1998). Failure of cytarabine in progressive multifocal leukoencephalopath y associated with human immunodeficiency virus infection. N Engl J Med 338: 1345–1351.
   PubMed Web of Science ®Google Scholar
• Hofman FM, Dohadwala MM, Wright AD, Hinton DR, Walker SM (1994). Exogenous tat protein activates central nervous system-derived endothelial cells. I Neuroimmunol 54: 19–28.
   PubMed Web of Science ®Google Scholar
• Holland NR, Power C, Mathews VP, Glass JD, Forman M, McArthur JC (1994). Cytomegalovirus encephalitis in AIDS. Neurology 44: 507–514.
   PubMed Web of Science ®Google Scholar
• Holman RC, Janssen RS, Buehler JW, Zelasky MT, Hooper WC (1991). Epidemiology of progressive multifocal leukoencephalopathy in the United States. Neurology 41: 1733–1736.
   PubMed Web of Science ®Google Scholar
• Kalayjian RC, Cohen ML, Bonomo RA, Flanigan TP (1993). Cytomegalovirus ventriculoencephalitis in AIDS. Medicine 72: 67–77.
   PubMedGoogle Scholar
• Koralnik IJ, Pasquier RA, Letvin NL (2001). JC virus-specific cytotoxic T lymphocytes in individuals with progres-sive multifocal leukoencephalopathy. I Virol 75: 3483–3487.
   Google Scholar
• Krupp LB, Lipton RB, Swerdlow ML, Leeds NE, Llena J (1985). Progressive multifocal leukoencephalopathy: clinical and radiographic features. Ann Neurol 17: 344–349.
   PubMed Web of Science ®Google Scholar
• Kure K, Llena JF, Lyman WD, Soeiro R, Weidenheim K, Hirano A, Dickson D (1991). Human immunodeficiency virus-1 infection of the nervous system. Hum Pathol 22: 700–710.
   Google Scholar
• Laurenson IF, Ross JC, Milne JR (1997). Microscopy and latex antigen negative cryptococcal meningitis. I Infect 36: 329–331.
   Google Scholar
• Leenders A, Reiss P, Portegies P, Clezy K, Hop W, Hoy J, Borleffs J, Allworth T, Kauffmann R, Jones P, Kroon F, Verbrugh H, de Marie S (1997). Liposomal amphotericin B (AmBisome) compared with amphotericin B both fol-lowed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis. AIDS 11: 1463–1471.
   PubMed Web of Science ®Google Scholar
• Levy R, Rothholtz V (1997). HIV-1-related neurologic dis-orders. Neuroimag Clin North Am 7: 527–547.
   Google Scholar
• Luft B, Remington J (1992). Toxoplasmic encephalitis in AIDS. Clin Infect Dis 15: 211–222.
   PubMed Web of Science ®Google Scholar
• Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR (1992). Pathogenesis and molecular biology of pro-gressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Micro Rev 5: 49–73.
   PubMed Web of Science ®Google Scholar
• Marra CM, Rajicic N, Barker DE, Cohen B, Clifford D, ACTG 363 team (2001). Prospective pilot study of cidofovir for HIV-associated progressive multifocal leukoencephalopath y. 8th Conf Retro and Opp Infect, Abstract 596.
   Google Scholar
• Martinez E, Garcia-Viejo M, Marcos M, Perez-Cuevas J, Blanco J, Mallolas J, Miro J, Gatell J (2000). Discontinua-tion of secondary prophylaxis for cryptococcal meningi-tis in HIV-infected patients responding to highly active antiretroviral therapy. AIDS 14: 2615–2617.
   PubMed Web of Science ®Google Scholar
• McCutchan JA (1995). Clinical impact of cytomegalovirus infections of the nervous system in patients with AIDS. Clin Infect Dis 21 (Suppl 2): S196–S201.
   Google Scholar
• McGowan J, Shah S (1998). Long-term remission of AIDS-related primary central nervous system lymphoma as-sociated with highly active antiretroviral therapy. AIDS 12: 952–953.
   PubMed Web of Science ®Google Scholar
• Monaco MC, Jensen PN, Hou J, Durham LC, Major EO (1998). Detection of JC virus DNA in human tonsil tis-sue: evidence for site of initial viral infection. I Virol 72: 918–923.
   Google Scholar
• Morgello S, Cho ES, Nielsen S, Devinsky O, Petito CK (1987). Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome. Hum Pathol 18: 289–297.
   PubMed Web of Science ®Google Scholar
• Murray H (1999). Toxoplasmosis. In AIDS Therapy. Dolin R, Masur H, Saag M (eds). New York: Churchill Living-stone, pp 307–327.
   Google Scholar
• Oursler K, Moore R, Chaisson R (1999). Risk factors for cryptococcal meningitis in HIV-infected patients. AIDS Res Human Retrovir 15: 625–631.
   Google Scholar
• Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ (1971). Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopath y. Lancet 1: 1257–1260.
   PubMed Web of Science ®Google Scholar
• Perrons CJ, Fox JD, Lucas SB, Brink NS, Tedder RS, Miller RF (1996). Detection of polyomaviral DNA in clinical samples from immunocompromised patients: correla-tion with clinical disease. I Infect 32: 205–209.
   Google Scholar
• Petito CK, Cho ES, Lemann W, Navia BA, Price RW (1986). Neuropathology of acquired immunodeficiency syn-drome: an autopsy review. I Neuropathol Exp Neurol 45: 635–646.
   PubMed Web of Science ®Google Scholar
• Pierce M, Johnson M, Maciunas R, Murray M, Allen G, Harbison M, Creasy J, Kessler R (1995). Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Intern Med 123: 594–598.
   Google Scholar
• Potasman I, Resnick L, Luft B, Remington J (1988). Intrathe-cal production of antibodies against Toxoplasma gondii in patients with toxoplasmic encephalitis and the ac-quired immunodeficiency syndrome (AIDS). Ann Intern Med 108: 49–51.
   PubMed Web of Science ®Google Scholar
• Power C, Kong PA, Crawford TO, Wesselingh S, Glass J, McArthur J, Trapp B (1993). Cerebral white matter changes in acquired immunodeficiency syndrome de-mentia: alterations of the blood-brain barrier. Ann Neu-rol 34: 339–350.
   PubMed Web of Science ®Google Scholar
• Price TA, Digioia RA, Simon GL (1992). Ganciclovir treat-ment of cytomegalovirus ventriculitis in a patient in-fected with human immunodeficiency virus. Clin Infect Dis 15: 606–608.
   PubMedGoogle Scholar
• Price D, Klein J, Fisher M, Main J, Bingham J, Coker R (1997). Potential role for granulocyte-macrophage colony-stimulating factor in the treatment of HIV-associated cryptococcal meningitis. AIDS 11: 693–694.
   Google Scholar
• Raez L, Patel P, Feun L, Restrepo A, Raub W, Cassileth P (1998). Natural history and prognostic factors for sur-vival in patients with acquired immune deficiency syn-drome (AIDS)-related primary central nervous system lymphoma (PCNSL). Crit Rev Oncol 9: 199–208.
   Google Scholar
• Renold C, Sugar A, Chave J, Perrin L, Delavelle J, Pizzolato G, Burkhard P, Gabriel V, Hirschel B (1992). Toxoplasma encephalitis in patients with the acquired immunodefi-ciency syndrome. Medicine 71: 224–239.
   PubMed Web of Science ®Google Scholar
• Roberts T, Storch G (1997). Multiplex PCR for diagnosis of AIDS-related central nervous system lymphoma and toxoplasmosis. I Clin Microbiol 35: 268–269.
   PubMedGoogle Scholar
• Ruiz A, Post J, Bundschu C, Ganz W, Georgiou M (1997). Primary central nervous system lymphoma in patients with AIDS. Neuroimag Clin North Am 7: 281–296.
   Google Scholar
• Saag M, Cloud G, Graybill R, Sobel J, Tuazon C, Johnson P, Fessel W, Moskovitz B, Wiesinger B, Cosmatos D, Riser L, Thomas C, Hafner R, Dismukes W (1999). A com-parison of itraconazole versus fluconazole as mainte-nance therapy for AIDS-associated cryptococcal menin-gitis. Clin Infect Dis 28: 291–296.
   PubMed Web of Science ®Google Scholar
• Saag M, Graybill R, Larsen R, Pappas P, Perfect J, Powderly W, Sobel J, Dismukes W (2000). Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 30: 710–718.
   PubMed Web of Science ®Google Scholar
• Saba J, Morlat P, Raffi F, Hazebroucq V, Joly V, Leport C, Vilde J (1993). Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS. Eur I Clin Microbiol Infect Dis 12: 853–856.
   PubMed Web of Science ®Google Scholar
• Sadler M, Brink N, Gazzard B (1998a). Management of in-tracerebral lesions in patients with HIV: a retrospective study with discussion of diagnostic problems. Q I Med 91: 205–217.
   Google Scholar
• Sadler M, Chinn R, Healy J, Fisher M, Nelson MR, Gazzard BG (1998b). New treatments for progressive multifocal leukoencephalopath y in HIV-1-infected patients. AIDS 12: 533–535.
   PubMedGoogle Scholar
• Salazar A, Podzamczer D, Rene R, Santin M, Perez J, Ferrer I, Fernandez-Viladrich P, Gudiol F (1995). Cy-tomegalovirus ventriculoencephalitis in AIDS patients. Scand J Infect Dis 27: 165–169.
   PubMed Web of Science ®Google Scholar
• Sanchez-Portocarrer o J, Perez-Cecilia E (1997). Intrac-erebral mass lesions in patients with human im-munodefeciency virus infection and cryptococcal meningitis. Diagn Microbiol Infect Dis 29: 193–198.
   Google Scholar
• Silber E, Sonnenberg P, Koornhof H, Morris L, Saffer D (1998). Dual infective pathology in patients with cryp-tococcal meningitis. Amer Acad of Neurol 51: 1213–1215.
   Google Scholar
• Simpson D, Tagliati M (1994). Neurologic manifestation of HIV infection. Ann Intern Med 121: 769–785.
   PubMed Web of Science ®Google Scholar
• Slobod K, Taylor G, Sandlund J, Furth P, Helton K, Sixbey J (2000). Epstein-Barr virus-targeted therapy for AIDS-related primary lymphoma of the central nervous sys-tem. Lancet 356: 1493–1494.
   PubMed Web of Science ®Google Scholar
• Sparano J (1995). Treatment of AIDS-related lymphomas. Curr Opin Oncol 7: 442–449.
   Google Scholar
• Tada H, Rappaport J, Lashgari M, Amini S, Wong-Staal F, Khalili K (1990). Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunode-ficiency virus in glial cells. Proc Nat] Acad Sci USA 87: 3479–3483.
   PubMed Web of Science ®Google Scholar
• Taoufik Y, Gasnault J, Karaterki A, Ferey M, Marchadier E, Goujard C, Lannuzel A, Delfraissy J, Dussoix E (1998). Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopa - thy. J Infect Dis 178: 1816–1820.
   PubMed Web of Science ®Google Scholar
• Tassie JM, Gasnault J, Bentata M, Deloumeaux J, Boue F, Billaud E, Costagliola D (1999). Survival improve-ment of AIDS-related progressive multifocal leukoen-cephalopathy in the era of protease inhibitors. AIDS 13: 1881–1887.
   Google Scholar
• Thorner A, Katz J (2001). Progressive multifocal leukoen-cephalopathy. Curr Infect Dis Rep 3: 352–359.
   Google Scholar
• Tornatore C, Berger JR, Houff SA, Curfman B, Meyers K, Winfield D, Major E (1992). Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopath y. Ann Neu-rol 31: 454–462.
   PubMed Web of Science ®Google Scholar
• Vago L, Cinque P, Sala E, Nebuloni M, Caldarelli R, Racc a S, Ferrante P, Trabattoni G, Costanzi G (1996). JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS pa-tients and normal subjects. J AIDS 12: 139–146.
   Google Scholar
• Vinters HV, Kwok MK, Ho HW, Anders K, Tomiyasu U, Wolfson W, Robert F (1989). Cytomegalovirus in the nervous system of patients with acquired immunode-ficiency syndrome. Brain 112: 245–268.
   PubMed Web of Science ®Google Scholar
• Walot I, Miller BL, Chang L, Mehringer CM (1996). Neu-roimaging findings in patients with AIDS. Clin Infect Dis 22: 906–919.
   Google Scholar
• Weber T, Turner R, Frye S, Ruf B, Haas J, Schielke E, Pohle H, Luke W, Luer W, Felgenhauer K, Hunsmann G (1994). Specific diagnosis of progressive multifocal leukoen-cephalopathy by polymerase chain reaction. I Infect Dis 169: 1138–1141.
   PubMed Web of Science ®Google Scholar
• Whiteman ML, Post MJ, Berger JR, Tate LG, Bell MD, Limonte LP (1993). Progressive mutifocal leukoen-cephalopathy in 47 HIV-seropositive patients: neu-roimaging with clinical and pathologic correlation. Ra-diology 187: 233–240.
   Google Scholar
• Wiselka MJ, Read R, Finch RG (1996). Response to oral and intravenous azithromycin in a patient with toxoplasma encephalitis and AIDS. J. Infection 33: 227–229.
   Google Scholar
• Woods M, MacGinley R, Eisen D, Allworth A (1998). HIV combination therapy: partial immune restitution un-masking latent cryptococcal infection. AIDS 12: 1491–1494.
   PubMed Web of Science ®Google Scholar
• Wright D, Schneider A, Berger J (1997). Central nervous system opportunistic infections. Neuroimag Clin North Am 7: 513–.
   Google Scholar
• Yiannoutsos CT, Maj or EO, Curfman B, Jensen P, Gravell M, Hou J, Clifford D, Hall C (1999). Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired im-munodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopath y. Ann Neu-rol 45: 816–819.
   PubMed Web of Science ®Google Scholar
• Zeind C, Cleveland K, Menon M, Brown J, Solomon D (1996). Cryptococcal meningitis in patients with the ac-quired immunodeficiency syndrome. Pharmacotherapy 16: 547–561.
   Google Scholar